🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs
7,238

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Page 35 of 151

  1. Carboplatin plus Paclitaxel

    United Therapeutics Europe Ltd

    Ovarian Cancer

    phase 2 small molecule active

    1 trial

  2. Carboplatino Hikma 10 mg/ml soluzione per infusione, Avastin 25 mg/ml concentrate for solution for infusion., Cisplatino Accord Healthcare Italia 1 mg/ml concentrato per soluzione per infusione, JEMPERLI 500 mg concentrate for solution for infusion

    GlaxoSmithKline

    Tumours, Gynecological

    phase 2 small molecule active

    1 trial

  3. CardiolRx

    Cardiol Therapeutics

    Acute Myocarditis

    phase 2 small molecule active

    1 trial

  4. CardiolRx

    Cardiol Therapeutics

    Acute Myocarditis

    phase 2 small molecule completed

    1 trial

  5. Carfilzomib 56 MG [Kyprolis]

    Samsung Bioepis NL B.V.

    Multiple Myeloma

    phase 2 small molecule active

    1 trial

  6. Cariprazine Oral Capsule [Vraylar]

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 2 small molecule terminated

    1 trial

  7. Carvedilol

    NORTHWEST BIOTHERAPEUTICS INC

    Post-Traumatic Stress Disorder

    phase 2 small molecule active

    1 trial

  8. Carvedilol

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule completed

    1 trial

  9. Casdatifan

    Arcus Biosciences

    Renal Cell Carcinoma

    phase 2 small molecule active

    1 trial

  10. Casdozokitug

    Coherus Oncology

    Hepatocellular Carcinoma

    phase 2 small molecule active

    1 trial

  11. Caudal Dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Inguinal Hernia

    phase 2 small molecule completed

    1 trial

  12. Cediranib

    United Therapeutics Europe Ltd

    Alveolar Soft-part Sarcoma

    phase 2 small molecule active

    1 trial

  13. Cefiderocol

    Shionogi B.V.

    Gram-negative Bacterial Infections

    phase 2 small molecule completed

    1 trial

  14. Ceftriaxone 1000mg + doxycycline 100 mg

    Hong Kong Baptist University

    Neisseria Gonorrhoeae Infection

    phase 2 small molecule completed

    1 trial

  15. Celaderm (Frozen Cultured Epidermal Allograft)

    Takeda

    Leg Ulcer

    phase 2 other completed

    1 trial

  16. Celecoxib

    United Therapeutics Europe Ltd

    Head and Neck Cancer

    phase 2 small molecule terminated

    1 trial

  17. Celecoxib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oral Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  18. Celgosivir

    60 DEGREES PHARMACEUTICALS, INC.

    Dengue Fever

    phase 2 small molecule terminated

    1 trial

  19. Cell infusion intraportal mononuclear bone marrow autologous and portal embolization of the affected segments.

    Lxo Ireland Designated Activity Company

    Liver Transplant Rejection

    phase 2 other completed

    1 trial

  20. Cell therapy for Inclusion Body Myositis (IBM) by muscle injection of autologous uncultured Adipose-Derived Stromal Vascular Fraction (ADSVF): a phase I trial

    Pari Pharma GmbH

    Inclusion Body Myositis

    phase 2 other active

    1 trial

  21. Cemiplimab

    Regeneron UK Limited

    Carcinoma, Non-Small-Cell Lung

    phase 2 small molecule active

    1 trial

  22. Cemiplimab

    Regeneron UK Limited

    Metastatic Solid Tumor

    phase 2 small molecule active

    1 trial

  23. Cemiplimab

    Regeneron UK Limited

    Hepatitis B Virus

    phase 2 mab terminated

    1 trial

  24. Cemiplimab

    Regeneron UK Limited

    Pleural Mesotheliomas

    phase 2 small molecule active

    1 trial

  25. Cemiplimab

    Regeneron UK Limited

    Colo-rectal Cancer

    phase 2 small molecule active

    1 trial

  26. Cemiplimab

    Regeneron UK Limited

    Hodgkin Lymphoma

    phase 2 small molecule terminated

    1 trial

  27. Cemiplimab

    Regeneron UK Limited

    NSCLC

    phase 2 small molecule active

    1 trial

  28. Cemiplimab

    Regeneron UK Limited

    Colorectal Cancer

    phase 2 small molecule active

    1 trial

  29. Cemiplimab

    Regeneron UK Limited

    Basal Cell Carcinoma (BCC)

    phase 2 small molecule active

    1 trial

  30. Cemiplimab

    Regeneron UK Limited

    High-Grade Glioma (HGG)

    phase 2 small molecule active

    1 trial

  31. Cemiplimab

    Regeneron UK Limited

    Lung Cancer (NSCLC)

    phase 2 small molecule active

    1 trial

  32. Cemiplimab

    Regeneron UK Limited

    Colon and Rectal Cancer

    phase 2 small molecule active

    1 trial

  33. Cemiplimab

    Regeneron UK Limited

    HIV Infections

    phase 2 mab terminated

    1 trial

  34. Cemiplimab

    Regeneron UK Limited

    Colon Cancer

    phase 2 small molecule active

    1 trial

  35. Cemiplimab

    Regeneron UK Limited

    Cervical Cancer

    phase 2 small molecule completed

    1 trial

  36. Cemiplimab

    Regeneron UK Limited

    Locally Recurrent Oral Cavity Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  37. Cemiplimab

    Regeneron UK Limited

    Locally Advanced Basal Cell Carcinoma

    phase 2 mab active

    1 trial

  38. Cemiplimab

    Regeneron UK Limited

    HPV-Related Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  39. Cemiplimab

    Regeneron UK Limited

    Bladder Urothelial Carcinoma

    phase 2 small molecule active

    1 trial

  40. Cemiplimab

    Regeneron UK Limited

    Head and Neck Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  41. Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)]

    Regeneron UK Limited

    Colon Cancer

    phase 2 small molecule active

    1 trial

  42. Cemiplimab 350 MG Intravenous Solution

    Regeneron UK Limited

    Clear Cell Renal Cell Carcinoma

    phase 2 small molecule active

    1 trial

  43. Cemiplimab 350 mg i.v. on day 1 of every 21 days cycle for 2 cycles

    Regeneron UK Limited

    Merkel Cell Carcinoma, Stage I

    phase 2 small molecule active

    1 trial

  44. Cemiplimab Plus Gemcitabine

    Regeneron UK Limited

    Pancreatic Ductal Adenocarcinoma (mPDAC)

    phase 2 small molecule active

    1 trial

  45. Cemiplimab and Fianlimab - 1, Fianlimab, Cemiplimab & Fianlimab - 2, LIBTAYO 350 mg concentrate for solution for infusion., Placebo for Fianlimab

    Lacuna Pharma Pty Ltd

    Melanoma

    phase 2 small molecule active

    1 trial

  46. Cemiplimab and Fianlimab - 1, Placebo, LIBTAYO 350 mg concentrate for solution for infusion., PEMETREXED, CARBOPLATIN, CISPLATIN, Cemiplimab & Fianlimab - 2, PACLITAXEL

    Lacuna Pharma Pty Ltd

    Resectable Non-small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  47. Cemiplimab-Rwlc

    Regeneron UK Limited

    Head and Neck Squamous Cell Carcinoma

    phase 2 small molecule terminated

    1 trial

  48. Cemiplimab-Rwlc

    Regeneron UK Limited

    Cutaneous Squamous Cell Carcinoma

    phase 2 small molecule terminated

    2 trials

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.